Aurinia Pharmaceuticals
Aurinia Pharmaceuticals is an Edmonton-based company developing therapies to treat patient populations suffering from disease states.
5
Funding Rounds
$451.6m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ne** So****** | - | - | - |
| Ri***** Gl****** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pe*** Gr******* | - | - | - |
| Ge**** M. Mi*** | - | - | - |
| Br**** Ba********** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Aurinia Pharmaceuticals has raised a total of $451.55m in funding over 5 rounds.
Key Insights:
- Aurinia Pharmaceuticals Post-IPO Equity, Dec 2019: $191.7m
- Aurinia Pharmaceuticals Post-IPO Equity, Mar 2017: $173.1m
- Aurinia Pharmaceuticals Post-IPO Equity, Dec 2016: $28.75m
- Aurinia Pharmaceuticals Post-IPO Equity, Feb 2014: $52m
- Aurinia Pharmaceuticals Post-IPO Equity, Sep 2013: $6m
Aurinia Pharmaceuticals Post-IPO Equity, Dec 2019
$191.7m
Aurinia Pharmaceuticals Post-IPO Equity, Mar 2017
$173.1m
Aurinia Pharmaceuticals Post-IPO Equity, Dec 2016
$28.75m
Aurinia Pharmaceuticals Post-IPO Equity, Feb 2014
$52m
Aurinia Pharmaceuticals Post-IPO Equity, Sep 2013
$6m
Industries
Aurinia Pharmaceuticals is active in the following industries:
- Therapeutics
- Medical diagnostics
- Technology
- Biology
- Biotechnology